PerkinElmer debuts ChemOffice+ Cloud

By The Science Advisory Board staff writers

November 10, 2020 -- PerkinElmer has introduced ChemOffice+ Cloud, a new application for its ChemDraw chemistry drawing software portfolio.

With ChemOffice+ Cloud, chemists can utilize new cross-document searching functionality to access and report on chemical structure data, according to the company. Users can organize data into collections for reference and communications around reporting, presenting, and publishing, as well as patent submissions, PerkinElmer said.

What's more, ChemOffice+ Cloud can tap into chemical drawings that exist in disparate Microsoft Office documents on various systems and online -- without opening individual files, according to PerkinElmer. As a result, chemists can then organize multiple molecules, reactions, and drawings in a collection and create lists of chemical objects to be used in future reporting and studies, the company said.

Via Google Patents, ChemOffice+ Cloud also enables integrated access to indexed and searchable chemical structures.

PerkinElmer to acquire Horizon Discovery for $383M
PerkinElmer has reached an agreement to acquire Horizon Discovery Group with an all-cash offer of approximately $383 million. The transaction is...
PerkinElmer introduces no-wash immunoassay for mitophagy dysfunction
PerkinElmer has debuted a no-wash ubiquitin phosphorylation at serine 65 immunoassay for studying defective mitophagy dysfunction associated with Parkinson's...
PerkinElmer immunoassay identifies anti-SARS-CoV-2 compounds
PerkinElmer's AlphaLisa immunoassay was used to support global research for effective COVID-19 therapeutics conducted by the National Center for Advancing...
PerkinElmer launches workstations for COVID-19 detection
PerkinElmer has launched a series of new workstations for SARS-CoV-2 testing.
PerkinElmer launches free COVID-19 data dashboards
PerkinElmer has launched two free, open access COVID-19 data dashboards to speed up the discovery of antivirals and vaccines for the infection.

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter